financetom
Business
financetom
/
Business
/
Lift maker Schindler will pass on some tariff costs to customers
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lift maker Schindler will pass on some tariff costs to customers
May 25, 2025 9:50 PM

April 30 (Reuters) - Swiss lift and escalator maker

Schindler will pass on some tariff costs to customers

while also working to improve efficiency in its supply chain,

CEO Paolo Compagna told Reuters on Wednesday.

The company estimates an annualised gross cost impact of 33

million Swiss francs ($40.01 million) from tariffs, with a gross

cost impact of 23 million Swiss francs in 2025.

The company said in an investor presentation that it had lowered

its market outlook for new installations in the Americas from

its prior assessment, which Compagna said reflected a weaker

start to the year in North America.

Schindler now expects the market to contract by up to 5% this

year after previously estimating 2025 growth of up to 5%.

The Americas account for 29% of Schindler's group revenue,

and more than 95% of the raw materials and components that the

company uses in products sold in the U.S. are sourced locally,

analysts at Jefferies said.

"The China tariffs do play a big role to our suppliers,"

Compagna said on a call with analysts, referencing suppliers

which import aluminium and steel.

Compagna told Reuters that steel and aluminium price hikes were

mostly mitigated for 2025 due to the company's existing

contracts with suppliers, but expressed less certainty for after

2025.

"So far, we don't have signals of a visible slowdown,"

Compagna said when asked about whether the company had seen any

change in customer buying patterns in the U.S. since the tariffs

were announced.

Lucerne-based Schindler reported a first-quarter order intake of

2.95 billion Swiss francs on Wednesday, a 6% rise from a year

earlier in local currencies. The company reported organic growth

across all regions except China, and reiterated its 2025

earnings guidance.

($1 = 0.8248 Swiss francs)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
GFL Environmental Strikes $5.59 Billion Deal to Sell Environmental Services Unit to Apollo, BC Partners
GFL Environmental Strikes $5.59 Billion Deal to Sell Environmental Services Unit to Apollo, BC Partners
Jan 7, 2025
08:55 AM EST, 01/07/2025 (MT Newswires) -- GFL Environmental ( GFL ) agreed to sell a majority stake in its environmental services business to funds managed by affiliates of Apollo Global Management ( APO ) and BC Partners in a deal worth 8 billion Canadian dollars ($5.59 billion). The Canadian waste management company expects to generate cash proceeds of about...
Norwegian Cruise Line Unit Plans $1.8 Billion Senior Notes Offering
Norwegian Cruise Line Unit Plans $1.8 Billion Senior Notes Offering
Jan 7, 2025
08:55 AM EST, 01/07/2025 (MT Newswires) -- Norwegian Cruise Line Holdings ( NCLH ) unit NCL said Tuesday that it plans to sell $1.8 billion in senior notes that mature in 2032 in a private offering. NCL said the proceeds, along with cash on hand, will be used to redeem $1.2 billion of its 5.875% senior notes that mature in...
CIBC Comments on Canada's International Merchandise Trade Deficit for November
CIBC Comments on Canada's International Merchandise Trade Deficit for November
Jan 7, 2025
08:54 AM EST, 01/07/2025 (MT Newswires) -- Canada's trade deficit in goods slimmed slightly in November, as exports rose more than imports, noted CIBC. Tuesday's C$323 million deficit was narrower than a revised C$500 million shortfall in the prior month -- previously reported at C$900 million -- and the consensus forecast that had expected little change, said the bank. Exports...
Johnson & Johnson Reports 'Statistically Significant' Data From Trial of Rybrevant, Lazcluze Combination to Treat Lung Cancer
Johnson & Johnson Reports 'Statistically Significant' Data From Trial of Rybrevant, Lazcluze Combination to Treat Lung Cancer
Jan 7, 2025
08:55 AM EST, 01/07/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) reported statistically significant topline results Tuesday from a phase 3 study evaluating the combination of Rybrevant and Lazcluze as a first-line therapy for patients with locally advanced or metastatic non-small cell lung cancer. The pharmaceutical company said the combination regimen, which avoids the use of chemotherapy, met...
Copyright 2023-2026 - www.financetom.com All Rights Reserved